Barré J - Search Results

1

Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A.

Gardier AM, Mathé D, Guédeney X, Barré J, Benvenutti C, Navarro N, Vernillet L, Loisance D, Cachera JP, Jacotot B, et al. Gardier AM, et al. Among authors: barre j. Ther Drug Monit. 1993 Aug;15(4):274-80. doi: 10.1097/00007691-199308000-00003. Ther Drug Monit. 1993. PMID: 8236361

2

Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.

Hamberger C, Urien S, Barre J, Brandebourger M, Lemaire M, Lang P, Buisson C, Loisance D, Cachera JP, Lagrue G, et al. Hamberger C, et al. Among authors: barre j. Ther Drug Monit. 1988;10(1):28-33. Ther Drug Monit. 1988. PMID: 3287706

3

Comparison of different methods for lysing whole blood to measure cyclosporin A by radioimmunoassay.

Hamberger C, Barre J, Urien S, Gardier A, Tillement JP. Hamberger C, et al. Among authors: barre j. Ther Drug Monit. 1988;10(4):501. Ther Drug Monit. 1988. PMID: 3201538 No abstract available.

4

In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood.

Combes O, Barré J, Duché JC, Vernillet L, Archimbaud Y, Marietta MP, Tillement JP, Urien S. Combes O, et al. Among authors: barre j. Invest New Drugs. 2000 Feb;18(1):1-5. doi: 10.1023/a:1006379730137. Invest New Drugs. 2000. PMID: 10830136

5

Problems in therapeutic drug monitoring: free drug level monitoring.

Barre J, Didey F, Delion F, Tillement JP. Barre J, et al. Ther Drug Monit. 1988;10(2):133-43. doi: 10.1097/00007691-198802000-00002. Ther Drug Monit. 1988. PMID: 3289143 Review.

6

[Circulating forms of cyclosporin A].

Barre J. Barre J. Therapie. 1992 Jul-Aug;47(4):301-4. Therapie. 1992. PMID: 1494792 Review. French.

7

In vitro studies on the blood distribution of almitrine.

Barré J, Didey F, Urien S, Riant P, Tillement JP. Barré J, et al. Pharmacology. 1989;38(6):381-7. doi: 10.1159/000138561. Pharmacology. 1989. PMID: 2573079

8

Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part I).

Zini R, Riant P, Barré J, Tillement JP. Zini R, et al. Among authors: barre j. Clin Pharmacokinet. 1990 Aug;19(2):147-59. doi: 10.2165/00003088-199019020-00004. Clin Pharmacokinet. 1990. PMID: 2199129 Review.

9

Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.

Cheymol G, Poirier JM, Barre J, Pradalier A, Dry J. Cheymol G, et al. Among authors: barre j. J Clin Pharmacol. 1987 Nov;27(11):874-9. doi: 10.1002/j.1552-4604.1987.tb05582.x. J Clin Pharmacol. 1987. PMID: 3429695

10

[Respective role of mifepristone (RU486) binding to blood and tissue proteins in its quantitative distribution in the body].

Grimaldi B, Barre J, Tillement JP. Grimaldi B, et al. Among authors: barre j. C R Acad Sci III. 1992;315(3):93-9. C R Acad Sci III. 1992. PMID: 1422922 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters